Officiële publicaties Crossject Deutsche Boerse AG

Aandelen

Vertraagde tijd Deutsche Boerse AG Andere beurzen 08:07:46 17-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,848 ^EUR	+1,20%		-0,11%	-59,30%

10/07	Crossject krijgt 7 miljoen euro overheidsfinanciering voor nieuw epinefrine product	MT
13/06	Crossject SA kondigt de benoeming aan van Dan Chiche als Chief Medical Officer Noord-Amerika	CI

Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24-10-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	24-10-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	21-10-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	21-10-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	13-10-22	CO
1st-half-year results	21-09-22	CO
Monthly statement on voting rights	31-08-22	CO
Corporate officers' Statement : Sale	26-06-22	CO
Corporate officers' Statement : Sale	26-06-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	23-06-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	23-06-22	CO
Share buyback	09-06-22	CO
Monthly statement on voting rights	30-04-22	CO
Monthly statement on voting rights	31-03-22	CO
Monthly statement on voting rights	28-02-22	CO
Corporate officers' Statement : -Other Types Operations	24-02-22	CO
Provisional calendar	11-02-22	CO
Monthly statement on voting rights	31-01-22	CO
Security operations	04-01-22	CO